Last reviewed · How we verify
NCT02688114
Healing of the Esophageal Mucosa After RFA of Barrett's Esophagus
NA trial testing Baseline surveillance endoscopy in Barrett Esophagus in 8 participants. Completed in 29 January 2020.
29 January 2020
Quick facts
| Lead sponsor | Dallas VA Medical Center |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | basic science |
| Enrollment | 8 |
| Start date | 18 October 2017 |
| Primary completion | 29 January 2020 |
| Estimated completion | 29 January 2020 |
| Sites | 2 locations across United States |
Drugs / interventions tested
- Baseline surveillance endoscopy
- Radiofrequency ablation
- Follow up endoscopy 1
- Follow up endoscopy 2
- Follow up endoscopy 3
Conditions studied
- Barrett Esophagus — all drugs for Barrett Esophagus →
Sponsor
Dallas VA Medical Center
Who can join
Adults 18 to 80, any sex, with Barrett Esophagus. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Radiofrequency ablation (RFA) is a mainstay of treatment for patients who have Barrett's esophagus (BE) with dysplasia. For unclear reasons, Barrett's esophagus recurs after successful RFA treatment in approximately 1/3 of patients. The aim of this study is to characterize the healing process of the esophageal mucosa, histologically and at the molecular level, after RFA for non-dysplastic and dysplastic Barrett's esophagus.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT02688114
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Barrett Esophagus
Currently open trials in the same condition.
- NCT07126535 — Impact of RFA on Esophageal Distensibility and Mucosal Impedance · recruiting
- NCT06746623 — Nonendoscopic Screening for Barrett's Esophagus in Veterans Without Chronic Reflux · NA · recruiting
- NCT06687603 — Multi-Site Detection of Barrett's Esophagus in Patients Without Chronic GERD Symptoms · NA · recruiting
- NCT06803147 — "Less-is-more in Barrett-surveillance" Care Evaluation of Barrett's Patients With Low-Risk in Whom Endoscopic Surveillan · recruiting
- NCT06693622 — Patient Preferences for Barrett's Esophagus and Esophageal Cancer Screening Tests · recruiting
Other Dallas VA Medical Center trials
Trials by the same sponsor.
- NCT04113057 — Home-based Walking Program With Smart Devices · NA · terminated
- NCT04611464 — Misoprostol for Spinal Stenosis · completed
- NCT04018872 — Evaluating the Effect of Itraconazole on Pathologic Complete Response Rates in Esophageal Cancer · Phase 2 · recruiting
- NCT04529083 — Mixed Reality Based System to Manage Phantom Pain Phantom Pain for Patients With Lower Limb Amputation · NA · completed
- NCT03511053 — Epidural Lavage Study for Lumbar Stenosis · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT02688114 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Dallas VA Medical Center
- Last refreshed: 11 September 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02688114.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing